Security key
152309100
Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA)
CUSIP: 152309100
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Ordinary Shares, nominal value GBP 0.002 per share
- Shares outstanding
- 154,150,943
- Total 13F shares
- 74,581,035
- Share change
- +2,707,155
- Total reported value
- $669,057,512
- Price per share
- $8.97
- Number of holders
- 40
- Value change
- +$23,146,015
- Number of buys
- 17
- Number of sells
- 21
Report period
Q1 2022
Institutions
40
Top holders
10
CNTA full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Centessa Pharmaceuticals plc SEC filings
Centessa Pharmaceuticals plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 152309100
Recent filing periods:
Top shareholders of CNTA - Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
|
Company · 10%+ Owner |
12%
|
18,123,892
|
$204,075,000 | — | 31 Dec 2021 | |
| Index Venture Life Associates VI Ltd |
13F
|
Company |
6.5%
|
9,961,789
|
$112,170,000 | — | 31 Dec 2021 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Company |
6.3%
|
9,681,818
|
$109,017,000 | — | 31 Dec 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.7%
|
5,743,397
|
$63,137,000 | — | 31 Dec 2021 | |
| Vida Ventures Advisors, LLC |
13F
|
Company |
2.6%
|
3,931,818
|
$44,272,000 | — | 31 Dec 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.3%
|
3,577,094
|
$40,278,000 | — | 31 Dec 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.6%
|
2,489,894
|
$28,036,000 | — | 31 Dec 2021 | |
| OUP Management Co., LLC |
13F
|
Company |
1.5%
|
2,341,891
|
$26,370,000 | — | 31 Dec 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
2,076,770
|
$23,384,000 | — | 31 Dec 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.95%
|
1,459,693
|
$16,436,000 | — | 31 Dec 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.81%
|
1,251,137
|
$14,088,000 | — | 31 Dec 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.73%
|
1,127,273
|
$12,693,000 | — | 31 Dec 2021 | |
| Venrock Adviser, LLC |
13F
|
Company |
0.73%
|
1,127,272
|
$12,693,000 | — | 31 Dec 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.71%
|
1,097,908
|
$12,362,000 | — | 31 Dec 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.7%
|
1,085,697
|
$12,225,000 | — | 31 Dec 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.57%
|
882,176
|
$9,933,000 | — | 31 Dec 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.52%
|
801,136
|
$9,021,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.47%
|
727,273
|
$8,189,000 | — | 31 Dec 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.37%
|
575,538
|
$6,480,000 | — | 31 Dec 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.34%
|
517,123
|
$5,823,000 | — | 31 Dec 2021 | |
| BVF INC/IL |
13F
|
Company |
0.29%
|
454,545
|
$5,118,000 | — | 31 Dec 2021 | |
| Logos Global Management LP |
13F
|
Company |
0.29%
|
454,545
|
$5,118,000 | — | 31 Dec 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.27%
|
419,144
|
$4,720,000 | — | 31 Dec 2021 | |
| Deep Track Capital, LP |
13F
|
Company |
0.26%
|
400,000
|
$4,504,000 | — | 31 Dec 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.22%
|
343,292
|
$3,866,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.22%
|
340,065
|
$3,829,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.19%
|
287,238
|
$3,234,000 | — | 31 Dec 2021 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.16%
|
239,041
|
$2,692,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
0.06%
|
94,300
|
$1,062,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
79,204
|
$892,000 | — | 31 Dec 2021 | |
| Verition Fund Management LLC |
13F
|
Company |
0.03%
|
50,000
|
$563,000 | — | 31 Dec 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
33,252
|
$374,000 | — | 31 Dec 2021 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.01%
|
22,200
|
$250,000 | — | 31 Dec 2021 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.01%
|
14,798
|
$167,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
14,065
|
$158,000 | — | 31 Dec 2021 | |
| Ascentis Independent Advisors |
13F
|
Company |
0.01%
|
13,870
|
$156,000 | — | 31 Dec 2021 | |
| Gyon Technologies Capital Management, LP |
13F
|
Company |
0.01%
|
10,426
|
$117,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
8,884
|
$100,000 | — | 31 Dec 2021 | |
| Lombard Odier SCmA Compagnie |
13F
|
Individual |
0%
|
5,820
|
$66,000 | — | 31 Dec 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
4,509
|
$51,000 | — | 31 Dec 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,029
|
$12,000 | — | 31 Dec 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
930
|
$10,000 | — | 31 Dec 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
750
|
$9,000 | — | 31 Dec 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
632
|
$7,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
496
|
$6,000 | — | 31 Dec 2021 | |
| ADIRONDACK TRUST CO |
13F
|
Company |
0%
|
400
|
$5,000 | — | 31 Dec 2021 | |
| State of Wyoming |
13F
|
Company |
0%
|
61
|
$1,000 | — | 31 Dec 2021 | |
| INDEX VENTURES LIFE VI (JERSEY) L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
149,421
|
$1,189,391 | — | 27 May 2021 | |
| Francesco de Rubertis |
3/4/5
|
Director |
—
class O/S missing
|
281,162
|
$2,238,050 | — | 21 Mar 2022 | |
| Aaron Kantoff |
3/4/5
|
Director |
—
class O/S missing
|
60,000
|
$477,600 | — | 18 Nov 2021 |
Institutional Holders of Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA) as of Q1 2022
As of 31 Mar 2022,
Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
74,581,035 shares.
The largest 10 holders included
Medicxi Ventures Management (Jersey) Ltd, Index Venture Life Associates VI Ltd, GENERAL ATLANTIC, L.P., JANUS HENDERSON GROUP PLC, Vida Ventures Advisors, LLC, RA CAPITAL MANAGEMENT, L.P., OUP Management Co., LLC, PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, and Samsara BioCapital, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
46
Q1 2022 holders
40
Holder diff
-6
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.